ArticleFrontiers in microbiology2021
Emergence and Genomic Characterization of a KPC-2-, NDM-1-, and IMP-4-Producing
Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Variable chlorhexidine MICs acrossAntimicrobial agents and chemotherapy · 2026Article
- Genomic characterisation and antimicrobial resistance ofFrontiers in cellular and infection microbiology · 2026Article
- Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases.Clinical microbiology reviews · 2025Review
- Genomic characteristics of ST6115 carbapenem-resistantFrontiers in microbiology · 2025Article
- Genome assembly ofFrontiers in microbiology · 2025Article
- Clonal dissemination of carbapenem-resistant ST477Frontiers in cellular and infection microbiology · 2025Article
- Emergence of blaBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Genomic Characterization of a Clinical NDM-1-ProducingMicroorganisms · 2024Article
- Prevalence of ST1049-KL5 carbapenem-resistant Klebsiella pneumoniae with a blaCommunications biology · 2024Article
- Molecular Characterization of a KPC-2- and NDM-1-ProducingInfection and drug resistance · 2024Article
- Multidrug-Resistant Klebsiella pneumoniae in a Patient with SARS-Cov-2 Pneumonia in an Intensive Care Unit in Guayaquil, Ecuador: A Case Report.The American journal of case reports · 2022Article
- Detection of IMP-4 and SFO-1 co-producing ST51Frontiers in cellular and infection microbiology · 2022Article
- A clinical KPC-producingFrontiers in microbiology · 2022Article
- Coexistence ofFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A rectal swab sample was collected from a patient with Guillain-Barré syndrome and enriched in lysogeny broth. Carbapenem-resistant bacteria were selected by China Blue agar plates containing 0.3 μg/ml meropenem. Carbapenemase-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.